Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
13 minute read
  • Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights
August 14, 1:48 PM
  During Monday's session, 201 stocks hit new 52-week lows.

AA

Read More
11 minute read
  • Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
August 11, 2:01 PM
  During the Friday's sesion, 157 stocks hit new 52-week lows.

ABVC

Read More
2 minute read
  • Analyst Ratings

Analyst Expectations for Coya Therapeutics’s Future

By Benzinga Insights
July 17, 5:00 PM
Within the last quarter, Coya Therapeutics (NASDAQ:COYA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

COYA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Coya Therapeutics’ Alzheimer’s Candidate Shows Lower Biomarker Levels Associated With Neuroinflammation

By Vandana Singh
July 17, 10:21 AM
Coya Therapeutics Inc (NASDAQ: COYA) reported results from an open-label proof-of-concept clinical study for low-dose interleukin 2 (ld IL-2) in patients 

COYA

Read More
2 minute read
  • Biotech
  • General

Coya Therapeutics Reports Additional Proof-of-Concept Clinical Biomarker Data In Patients With Alzheimer’s Disease

By Benzinga Newsdesk
July 17, 7:02 AM
The open-label study evaluated the safety and tolerability, biological activity, blood biomarkers and preliminary efficacy of low-dose interleukin 2 (ld IL-2) in 8 patients with Alzheimer's disease (AD). The

COYA

Read More
1 minute read
  • Analyst Ratings

The Latest Analyst Ratings for Coya Therapeutics

By Benzinga Insights
June 8, 12:00 PM
Coya Therapeutics (NASDAQ:COYA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

COYA

Read More
2 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

Marsh & McLennan To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday

By Lisa Levin
June 8, 8:31 AM
Raymond James cut the price target for Brinker International, Inc. (NYSE: EAT) from $46 to $42.5. Raymond James analyst Brian Vaccaro maintained an Outperform rating. Brinker shares fell 6.3% to close at $36.39 on Tuesday.

CARR

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Blood Biomarker, Brain Imaging Data Shows Coya Therapeutics’ Alzheimer’s Candidate Lowers Neuroinflammation

By Vandana Singh
June 7, 2:00 PM
Coya Therapeutics Inc (NASDAQ: COYA) reported additional biomarker and brain imaging results from an open-label proof-of-concept study for COYA 301 for 

COYA

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights
June 7, 9:06 AM
Gainers Avrobio (NASDAQ:AVRO) stock rose 11.9% to $1.22 during Wednesday’s pre-market session. The company’s market cap stands at…

ALLR

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket

By Lisa Levin
June 6, 8:36 AM
Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.

ACMR

Posts pagination

Previous 1 2 3 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service